One of the most popular champions right now is Zeri – the Marksman from Zaun, who was introduced to the League of Legends (LoL) community earlier this year. Despite her brief appearance, Zeri has proven to be a top-tier choice for the Bot Lane position. In tournaments across all regions, she is consistently one of the most prioritized champions for bans and picks.

However, Zeri has also become the most headache-inducing champion for Riot. Her power is so “unreal” that the publisher has to constantly adjust her strength through updates. Not to mention, besides the major patches, there are also numerous minor tweaks related to Zeri. As a result, any team that leaves Zeri open for the opponent is likely to face defeat due to the unstoppable power progression of the Spark of Zaun.

Recently, according to information from the upcoming 12.14 update, Zeri will continue to be on the list for adjustments. This will mark her 12th adjustment in just 9 patches from Riot. Since her release to the LoL community, there was only one period from patch 12.8 to 12.9 where Zeri did not receive any changes.

Current statistics show that Zeri’s win rate in ranked matches has reached 59% – a very high figure. Even when it drops to its lowest, it still hovers around 40%. These numbers adequately reflect the incredible power of this champion. And the LoL community certainly did not miss the opportunity to mock Riot’s “200 years of gaming experience,” primarily targeting August – the designer behind Zeri.

– “That’s an August product.” (August is the creator of many champions in LoL, including the “bug king” Viego)
– “I can’t believe my favorite champion designer – August made this champion.”
– “The last 4 champions from August have all been majorly flawed products.”
– “Overall, a failed design.”
However, it can be seen that Zeri, along with previous champions like Viego and Akali…, Riot is still struggling to design champions that are powerful enough while ensuring their criteria for “a balanced game.” And it seems that Riot’s efforts have yet to yield effective results.